PMV Pharmaceuticals (PMVP) Competitors $1.50 0.00 (0.00%) (As of 12/20/2024 05:30 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends PMVP vs. JSPR, TNGX, VALN, IMMP, FDMT, CCCC, LRMR, BNTC, CMPS, and FHTXShould you be buying PMV Pharmaceuticals stock or one of its competitors? The main competitors of PMV Pharmaceuticals include Jasper Therapeutics (JSPR), Tango Therapeutics (TNGX), Valneva (VALN), Immutep (IMMP), 4D Molecular Therapeutics (FDMT), C4 Therapeutics (CCCC), Larimar Therapeutics (LRMR), Benitec Biopharma (BNTC), COMPASS Pathways (CMPS), and Foghorn Therapeutics (FHTX). These companies are all part of the "pharmaceutical products" industry. PMV Pharmaceuticals vs. Jasper Therapeutics Tango Therapeutics Valneva Immutep 4D Molecular Therapeutics C4 Therapeutics Larimar Therapeutics Benitec Biopharma COMPASS Pathways Foghorn Therapeutics Jasper Therapeutics (NASDAQ:JSPR) and PMV Pharmaceuticals (NASDAQ:PMVP) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, risk, earnings, valuation, community ranking, analyst recommendations, media sentiment, dividends and institutional ownership. Is JSPR or PMVP more profitable? PMV Pharmaceuticals' return on equity of -24.20% beat Jasper Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Jasper TherapeuticsN/A -67.64% -58.53% PMV Pharmaceuticals N/A -24.20%-21.67% Does the MarketBeat Community prefer JSPR or PMVP? Jasper Therapeutics received 17 more outperform votes than PMV Pharmaceuticals when rated by MarketBeat users. Likewise, 88.89% of users gave Jasper Therapeutics an outperform vote while only 62.16% of users gave PMV Pharmaceuticals an outperform vote. CompanyUnderperformOutperformJasper TherapeuticsOutperform Votes4088.89% Underperform Votes511.11%PMV PharmaceuticalsOutperform Votes2362.16% Underperform Votes1437.84% Do institutionals & insiders have more ownership in JSPR or PMVP? 79.8% of Jasper Therapeutics shares are held by institutional investors. Comparatively, 90.2% of PMV Pharmaceuticals shares are held by institutional investors. 2.7% of Jasper Therapeutics shares are held by company insiders. Comparatively, 7.6% of PMV Pharmaceuticals shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. Which has more volatility & risk, JSPR or PMVP? Jasper Therapeutics has a beta of 2.18, meaning that its stock price is 118% more volatile than the S&P 500. Comparatively, PMV Pharmaceuticals has a beta of 1.47, meaning that its stock price is 47% more volatile than the S&P 500. Do analysts rate JSPR or PMVP? Jasper Therapeutics presently has a consensus price target of $73.38, suggesting a potential upside of 240.17%. PMV Pharmaceuticals has a consensus price target of $5.80, suggesting a potential upside of 286.67%. Given PMV Pharmaceuticals' stronger consensus rating and higher possible upside, analysts clearly believe PMV Pharmaceuticals is more favorable than Jasper Therapeutics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Jasper Therapeutics 0 Sell rating(s) 0 Hold rating(s) 10 Buy rating(s) 0 Strong Buy rating(s) 3.00PMV Pharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 5 Buy rating(s) 1 Strong Buy rating(s) 3.17 Which has higher earnings and valuation, JSPR or PMVP? Jasper Therapeutics is trading at a lower price-to-earnings ratio than PMV Pharmaceuticals, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioJasper TherapeuticsN/AN/A-$64.46M-$4.74-4.55PMV PharmaceuticalsN/AN/A-$68.96M-$1.00-1.50 Does the media refer more to JSPR or PMVP? In the previous week, Jasper Therapeutics had 1 more articles in the media than PMV Pharmaceuticals. MarketBeat recorded 1 mentions for Jasper Therapeutics and 0 mentions for PMV Pharmaceuticals. Jasper Therapeutics' average media sentiment score of 1.82 beat PMV Pharmaceuticals' score of 0.00 indicating that Jasper Therapeutics is being referred to more favorably in the media. Company Overall Sentiment Jasper Therapeutics Very Positive PMV Pharmaceuticals Neutral SummaryPMV Pharmaceuticals beats Jasper Therapeutics on 9 of the 16 factors compared between the two stocks. Ad Diversified Trading InstituteCombine the QQQ, IWM and SPY in one tradeIf you’ve been investing in the major indexes for the last 20 years, you may need a new strategy. Because the Dow Jones has returned just 349%... The Russell 2000 has returned just 397%... And the S&P 500 has returned just 450%. And although I can’t guarantee results or against losses… I want to tell you about my “2-Click Trade” that has encapsulated more than the return of ALL THREE OF THOSE INDEXES COMBINED… Plus, it targets multiple overnight payouts in a month with 84.3% accuracy! While I cannot promise future returns or against losses…You can find out about this “2-Click Trade” here. Get PMV Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for PMVP and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PMVP vs. The Competition Export to ExcelMetricPMV PharmaceuticalsPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$77.62M$6.57B$5.02B$9.08BDividend YieldN/A3.09%4.87%4.20%P/E Ratio-1.5010.55135.0817.16Price / SalesN/A194.011,120.30115.67Price / CashN/A57.1640.5837.88Price / Book0.345.104.754.78Net Income-$68.96M$151.51M$118.50M$225.60M7 Day Performance-5.06%-2.13%-1.85%-1.21%1 Month Performance-6.83%-3.13%11.28%3.09%1 Year Performance-45.85%11.54%29.91%16.48% PMV Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PMVPPMV Pharmaceuticals1.7962 of 5 stars$1.50flat$5.80+286.7%-34.5%$77.62MN/A-1.5050Positive NewsJSPRJasper Therapeutics2.3333 of 5 stars$21.42+4.0%$73.38+242.6%+290.1%$321.32MN/A-4.3520Positive NewsTNGXTango Therapeutics1.8423 of 5 stars$2.98-2.6%$13.14+341.0%-68.5%$320.11M$43.38M-2.5990News CoverageVALNValneva2.1578 of 5 stars$3.81-3.1%$18.50+385.6%-62.2%$309.56M$165.52M-30.23700News CoverageHigh Trading VolumeIMMPImmutep1.4305 of 5 stars$2.08-4.6%$8.50+308.7%-13.2%$302.56M$5.14M0.002,021FDMT4D Molecular Therapeutics2.5949 of 5 stars$6.54+0.6%$42.13+544.1%-66.9%$302.33M$17,000.00-2.28201Analyst ForecastCCCCC4 Therapeutics2.0625 of 5 stars$4.28-2.3%$10.00+133.6%-9.2%$302.12M$33.67M-2.58150Analyst UpgradeNews CoveragePositive NewsLRMRLarimar Therapeutics1.5701 of 5 stars$4.70-23.8%$20.43+334.7%+4.4%$299.91MN/A-3.5630Analyst RevisionNews CoverageHigh Trading VolumeBNTCBenitec Biopharma3.5736 of 5 stars$12.76+8.4%$24.43+91.4%+277.8%$296.29M$80,000.000.0020Analyst RevisionCMPSCOMPASS Pathways2.8367 of 5 stars$4.30+1.9%$33.60+681.4%-47.3%$294.21MN/A-1.92120Positive NewsFHTXFoghorn Therapeutics2.8871 of 5 stars$5.27-0.6%$15.20+188.4%-14.0%$292.98M$25.52M-2.63120Analyst ForecastAnalyst RevisionNews CoverageGap DownHigh Trading Volume Related Companies and Tools Related Companies Jasper Therapeutics Alternatives Tango Therapeutics Alternatives Valneva Alternatives Immutep Alternatives 4D Molecular Therapeutics Alternatives C4 Therapeutics Alternatives Larimar Therapeutics Alternatives Benitec Biopharma Alternatives COMPASS Pathways Alternatives Foghorn Therapeutics Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:PMVP) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PMV Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share PMV Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
